Send to

Choose Destination
See comment in PubMed Commons below
Breast Dis. 2005-2006;23:67-71.

Adjuvant systemic therapy in young women.

Author information

  • 1Division of Hematology/Oncology, University of North Carolina at Chapel Hill, 27599-7305, USA.


About a third of all newly diagnosed breast cancers occur in women under the age of 50 [1,2]. Young women face many of the same adjuvant treatment issues that their postmenopausal counterparts encounter. Unfortunately, they also experience issues that are unique to their age, their hormonal status, and their longer life expectancy. We will examine the issues regarding cytotoxic and biologic therapy as well as the controversies regarding optimal endocrine and chemoendocrine therapy in the premenopausal woman, and we will explore some of the survivorship issues faced by young women after breast cancer therapy.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for IOS Press
    Loading ...
    Write to the Help Desk